Marinomed Biotech AG

Declaration of Voting Results & Voting Rights Announcements • Feb 5, 2019

Publication Date: 05.02.2019 19:06 EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018 Linz, 4.2.2019 Overview 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Acquisition or disposal of voting rights 3. Person subject to notification obligation Name: Privatstiftung für die Standorterhaltung in Oberösterreich City: Linz Country: Österreich 4. Name of shareholder(s): Invest Unternehmensbeteiligungs Aktiengesellschaft

• 1. Date on which the threshold was crossed or reached: 1.2.2019
• 1. Total positions

____________
		% of voting
	% of voting			rights through Total of both Total number of
	rights attached financial/other in % (7.A +			voting rights
	to shares (7.A) instruments		7.B)	of issuer
__ _______________ (7.B.1+7.B.2) __ __
Resulting
situation on
the date on	8,70 %	0,00 %	8,70 %	1 260 000
which threshold
was crossed /
_reached __ __ __ __
Position of
previous
notification
(if_applicable) __ __ __ ___

Details

7. Notified details of the resulting situation:

				____________
A:Voting_rights_attached_to_shares______
			_Numberof_voting_rights _______%of_voting_rights____
	Direct	Indirect	Direct	Indirect
ISIN Code				(Sec 130 BörseG (Sec 133 BörseG (Sec 130 BörseG (Sec 133 BörseG
				___ 2018)__ _2018) __2018)_ 2018)___
				ATMARINOMED6_ __ ________109_605 _______________ __________8,70%
				SUBTOTAL_A__ ____________109_605____________ _____________8,70%_______

______________________________________________________________________________ |B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG | |2018__________________________________________________________________________| | | | |Number of voting | | | | | | rights that may | | | Type of | | | be | % of voting | | instrument |Expiration Date|Exercise Period|acquired if the | rights | | | | | instrument is | | |_____________|_______________|_______________|____exercised____|______________| |_____________|_______________|_SUBTOTAL_B.1__|_________________|______________|

	___________ B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG
	2018_____________
Type of	Expiration Exercise		Physical /	Number of		% of voting
instrument	Date	Period	Cash	voting rights		rights
	__ _ ___________ Settlement__ ____ ______
	__ _ __ SUBTOTALB.2_ __ _

1. Information in relation to the person subject to the notification obligation: Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

	________________
				Financial/
		Directly	Shares	other
No.	Name	controlled	held	instruments Total of
		by No.	directly	held	both (%)
			(%)	directly
	__ ___ _ _ _(%) ____
	Privatstiftung für die
1	Standorterhaltung in
	__ Oberösterreich__ _ _ __ _
	2___ IAG_Beteiligungen_GmbH _1 _ _ _
	Invest
3	Unternehmensbeteiligungs	2	8,70 %		8,70 %
	__ Aktiengesellschaft_ _ _ __ ____

1. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights. 10. Sonstige Kommentare: -

---

Linz am 4.2.2019

end of announcement euro adhoc

issuer: Marinomed Biotech AG Veterinärplatz 1 A-1210 Wien phone: 0043250774460 FAX: 0043250774493 mail: office@marinomed.com WWW: www.marinomed.com ISIN: ATMARINOMED6, AT0000A1WD52 indexes: stockmarkets: Wien language: English

Aussendung übermittelt durch euro adhoc The European Investor Relations Service